Sorrento receives Clinical Laboratory Improvement Amendments (CLIA) license from the State of California for clinical sample testing
Sorrento intends to initially offer three diagnostic tests for SARS-CoV-2 infection:
– RT-PCR Emergency Use Authorization (EUA)-approved test using nasal pharyngeal swab
– Laboratory developed test (COVI-STIX) using shallow nasal swab
– Laboratory
Neueste Kommentare